Ligand Pharmaceuticals
LGND
#2745
Rank
A$9.08 B
Marketcap
A$454.36
Share price
2.60%
Change (1 day)
41.16%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2026 (TTM): A$0.36 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.29 Billion. In 2025 the company made an earning of A$0.23 Billion, an increase over its 2024 earnings that were of A$8.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.36 B54.33%
2025 A$0.23 B2848.57%
2024 A$8.02 M-91.37%
2023 A$93.02 M-7.59%
2022 A$0.10 B4%
2021 A$96.79 M296.42%
2020 A$24.41 M-97.97%
2019 A$1.20 B275.62%
2018 A$0.32 B237.48%
2017 A$94.96 M49.05%
2016 A$63.71 M55.41%
2015 A$40.99 M36.87%
2014 A$29.95 M29.59%
2013 A$23.11 M1309.35%
2012 A$1.64 M-43.97%
2011 A$2.92 M-113.19%
2010 -A$22.2 Million59.86%
2009 -A$13.89 Million-61.33%
2008 -A$35.91 Million-58.75%
2007 -A$87.04 Million20.52%
2006 -A$72.22 Million81.27%
2005 -A$39.84 Million
2003 -A$27.74 Million-20.6%
2002 -A$34.93 Million4.38%
2001 -A$33.47 Million-48.83%
2000 -A$65.4 Million-19.74%
1999 -A$81.48 Million-19.06%
1998 -A$0.11 Billion126.71%
1997 -A$44.41 Million-5.83%
1996 -A$47.15 Million136.23%
1995 -A$19.96 Million-33.97%
1994 -A$30.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.07 B 7,567.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$9.98 B 2,728.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$50.28 B 14,140.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.87 B 4,113.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.7 Billion-297.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.12 B 3,049.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.38 B 4,541.37%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$10.34 B 2,830.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-A$89.5 Million-125.35%๐Ÿ‡บ๐Ÿ‡ธ USA